These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26306740)
21. [Clinical course and prognosis in SLE patients with pulmonary hypertension: a comparative study with primary pulmonary hypertension]. Fusegawa S; Mikami T; Hashimoto M; Yamada Y; Kobayashi T; Yasuda H; Sagawa A; Fujisaku A Kokyu To Junkan; 1991 Aug; 39(8):819-23. PubMed ID: 1925104 [TBL] [Abstract][Full Text] [Related]
22. Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol. Álvarez Troncoso J; Soto Abánades C; Robles-Marhuenda Á; Alcolea Batres S; Fernández Velilla Peña M; Jiménez Valero S; Sorriguieta Torre R; Rios-Blanco JJ RMD Open; 2024 Jan; 10(1):. PubMed ID: 38191213 [TBL] [Abstract][Full Text] [Related]
23. The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines. Li Y; Qian J; Dong X; Zhao J; Wang Q; Wang Y; Zeng X; Tian Z; Li M Arthritis Res Ther; 2024 May; 26(1):109. PubMed ID: 38802957 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566 [TBL] [Abstract][Full Text] [Related]
25. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients. Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672 [TBL] [Abstract][Full Text] [Related]
26. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms. Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901 [TBL] [Abstract][Full Text] [Related]
27. Hyperuricemia in systemic lupus erythematosus: is it associated with the neuropsychiatric manifestations of the disease? Sheikh M; Movassaghi S; Khaledi M; Moghaddassi M Rev Bras Reumatol Engl Ed; 2016; 56(6):471-477. PubMed ID: 27914592 [TBL] [Abstract][Full Text] [Related]
28. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? Ugolini-Lopes MR; Gavinier SS; Leon E; Viana VT; Borba EF; Bonfá E Clin Rheumatol; 2019 Oct; 38(10):2777-2783. PubMed ID: 31154554 [TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus. Tanaseanu C; Tudor S; Tamsulea I; Marta D; Manea G; Moldoveanu E Eur J Med Res; 2007 Apr; 12(4):145-51. PubMed ID: 17509958 [TBL] [Abstract][Full Text] [Related]
31. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients. Reátegui-Sokolova C; Ugarte-Gil MF; Gamboa-Cárdenas RV; Zevallos F; Cucho-Venegas JM; Alfaro-Lozano JL; Medina M; Rodriguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos RA Clin Rheumatol; 2017 Apr; 36(4):845-852. PubMed ID: 28101832 [TBL] [Abstract][Full Text] [Related]
32. Predictors of carotid atherosclerosis in systemic lupus erythematosus. Maksimowicz-McKinnon K; Magder LS; Petri M J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002 [TBL] [Abstract][Full Text] [Related]
33. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Foïs E; Le Guern V; Dupuy A; Humbert M; Mouthon L; Guillevin L Clin Exp Rheumatol; 2010; 28(6):836-41. PubMed ID: 21205461 [TBL] [Abstract][Full Text] [Related]
34. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Yang T; Chu CH; Bai CH; You SL; Chou YC; Chou WY; Chien KL; Hwang LC; Su TC; Tseng CH; Sun CA Atherosclerosis; 2012 Feb; 220(2):525-31. PubMed ID: 22154195 [TBL] [Abstract][Full Text] [Related]
35. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Ruiz-Irastorza G; Garmendia M; Villar I; Egurbide MV; Aguirre C Autoimmun Rev; 2013 Jan; 12(3):410-5. PubMed ID: 22841984 [TBL] [Abstract][Full Text] [Related]
37. Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis. Uk Kang T; Park KY; Kim HJ; Ahn HS; Yim SY; Jun JB Mod Rheumatol; 2019 Nov; 29(6):1031-1041. PubMed ID: 30334638 [No Abstract] [Full Text] [Related]
38. A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients. Lin CS; Hung YJ; Chen GY; Tzeng TF; Lee DY; Chen CY; Huang WP; Huang CH Int J Cardiol; 2011 May; 148(3):325-30. PubMed ID: 20053470 [TBL] [Abstract][Full Text] [Related]
39. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China. Chen D; Zhang H; Gao Y; Lu Z; Yao Z; Jiang Y; Lin X; Wu C; Yang X; Tan A; Mo Z Clin Chim Acta; 2015 Jun; 446():226-30. PubMed ID: 25913163 [TBL] [Abstract][Full Text] [Related]
40. [Systemic lupus erythematosus associated pulmonary arterial hypertension: clinical analysis of 91 cases]. Teng J; Zhang W Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):969-72. PubMed ID: 24851680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]